ENTITY

HLB Therapeutics (115450 KS)

Analysis

Health Care • South Korea

HLB Therapeutics Co.,Ltd. operates pharmaceutical development businesses. The Company develops gene medicines, cell medicines, and other medical products. HLB Therapeutics conducts businesses in South Korea.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00